This project has been flagged by a community member as inappropriate due to reason below.*
Expert Interview
Slingshot members are talking to an expert! The topic is:
A Second Look at the efficacy of AXS-05 in the treatment of Alzheimer's Disease Agitation
Ticker(s): AXSMWho's the expert?
Institution: Heritage Medical Associates
- Extensive experience in Headache and Neuromuscular & Movement Disorders.
- Currently manages 80 patients with AD agitation
- Board certified in both Neurology and Vascular Neurology and is a clinical assistant professor of neurology at Vanderbilt.
Interview GoalTo discuss safety and efficacy of AXS-05 after recent ACCORD Phase 3 Trial data release
Do you want answers to these questions?
Slingshot Insights Explained
Expert research benefits investors by giving them timely access to unbiased real world perspectives on highly specialized topics. Slingshot Insights' crowdfunded model makes this access available at a fraction of the cost of other expert networks.
Reason
*Slingshot Insights provides access to information, not investment advice. We work to support you and facilitate access to experts; however we are not responsible for monitoring calls for the disclosure of MNPI. You should obtain financial, legal and tax advice from your qualified and licensed advisers before deciding to invest in any security.
